The viral protein corona directs viral pathogenesis and amyloid aggregation
Open accessPublished version of a preprint
Abstract
Abstract Artificial nanoparticles accumulate a protein corona layer in biological fluids, which significantly influences their bioactivity. As nanosized obligate intracellular parasites, viruses share many biophysical properties with artificial nanoparticles in extracellular environments and here we show that respiratory syncytial virus (RSV) and herpes simplex virus type 1 (HSV-1) accumulate a rich and distinctive protein corona in different biological fluids. Moreover, we show that corona pre-coating differentially affects viral infectivity and immune cell activation. In addition, we demonstrate that viruses bind amyloidogenic peptides in their corona and catalyze amyloid formation via surface-assisted heterogeneous nucleation. Importantly, we show that HSV-1 catalyzes the aggregation of the amyloid β-peptide (Aβ 42 ), a major constituent of amyloid plaques in Alzheimer’s disease, in vitro and in animal models. Our results highlight the viral protein corona as an acquired structural layer that is critical for viral–host interactions and illustrate a mechanistic convergence between viral and amyloid pathologies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HSV-1 viral particles directly catalyze Aβ42 fibrillization in vitro by nucleating aggregation on the viral surface.
“In support of this theory, HSV-1 viral particles have recently been shown to directly catalyze the fibrillization of Aβ42 in vitro by nucleating aggregation via contact with the viral surface (Ezzat et al., 2019).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Ezzat et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 73 · Cited by 209
- Authors
- Ezzat, K., Pernemalm, M., Pålsson, S., Roberts, T. C., Järver, P., Dondalska, A., Bestas, B., Sobkowiak, M. J., Levänen, B., Sköld, M., Thompson, E. A., Saher, O., Kari, O. K., Lajunen, T., Sverremark Ekström, E., Nilsson, C., Ishchenko, Y., Malm, T., Wood, M. J. A., Power, U. F., Masich, S., Lindén, A., Sandberg, J. K., Lehtiö, J., Spetz, A.-L., & EL Andaloussi, S.
- Affiliations
- Stockholm University (SE)
- Science for Life Laboratory (SE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Cairo University (EG)
- University of Helsinki (FI)
- University of Eastern Finland (FI)
- University of Oxford (GB)
- Queen's University Belfast (GB)
- Corresponding author
- Ezzat, Kariem
- ORCID
- Ezzat, Kariem
- Pernemalm, Maria
- Pålsson, Sandra
- Roberts, Thomas C.
- Järver, Peter
- Dondalska, Aleksandra
- Bestas, Burcu
- Thompson, Elizabeth A.
- Saher, Osama
- Kari, Otto K.
- Lajunen, Tatu
- Sverremark Ekström, Eva
- Nilsson, Caroline
- Ishchenko, Yevheniia
- Malm, Tarja
- Wood, Matthew J. A.
- Power, Ultan F.
- Masich, Sergej
- Lindén, Anders
- Sandberg, Johan K.
- Lehtiö, Janne
- Spetz, Anna-Lena
- Venue
- Nature Communications
- Published
- 2019-05-27
- Volume
- 10
- Issue
- 1
- Pages
- 2331-2331
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC6536551
- OpenAlex
- W2949417727
- Cited by
- 209
- References
- 73
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 19 · 2023: 30 · 2022: 35 · 2021: 40 · 2020: 40 · 2019: 7 · 2018: 2
- FWCI
- 20.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Svenska Sällskapet för Medicinsk Forskning
- Vetenskapsrådet
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- respiratory syncytial virus, herpes simplex virus type 1, amyloid fibril formation, amyloid-beta 42, heterogeneous nucleation, viral infectivity, immune cell activation, host-virus interaction, Alzheimer's disease, amyloid plaques, amyloidogenic peptides
- MeSH terms
- Protein Corona, Alzheimer Disease, Animals, Bronchoalveolar Lavage Fluid, Chlorocebus aethiops, Disease Models, Animal, Female, Herpes Simplex, Humans, Male, Mice, Transgenic, Peptide Fragments, Vero Cells, Amyloid beta-Peptides, Respiratory Syncytial Virus, Human, Herpesvirus 1, Human, Respiratory Syncytial Virus Infections, Cell Line, Tumor, Mice, Host-Pathogen Interactions, Healthy Volunteers, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review